Exploratory Biomarker Findings from Cohort 2 of MODUL: an Adaptable, Phase 2, Signal-Seeking Trial of Fluoropyrimidine + Bevacizumab ± Atezolizumab Maintenance Therapy for BRAFwt Metastatic Colorectal Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2021)
关键词
Metastatic Colorectal Cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要